Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems

AIMS: This study assessed the performance of a new fully automated immunoassay, ARCHITECT B.R.A.H.M.S procalcitonin (PCT), comparing the results with other commercial assays on routine clinical specimens. METHODS: At nine sites from eight countries, precision analysis was carried out on controls by...

Descripción completa

Detalles Bibliográficos
Autores principales: Soh, A., Binder, L., Clough, M., Hernandez, M. Hernandez, Lefèvre, G., Mostert, K., Nguyen, T.B., Otte, K.-M., Portakal, O., Sandri, M.S., Yen, J.L., Huang, J., Beshiri, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249413/
https://www.ncbi.nlm.nih.gov/pubmed/30519621
http://dx.doi.org/10.1016/j.plabm.2018.e00110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249413/
https://www.ncbi.nlm.nih.gov/pubmed/30519621
http://dx.doi.org/10.1016/j.plabm.2018.e00110

Ejemplares similares